Issue 11, 2022

Neutralizing SARS-CoV-2 by dimeric side chain-to-side chain cross-linked ACE2 peptide mimetics

Abstract

We present the finding of a dimeric ACE2 peptide mimetic designed through side chain cross-linking and covalent dimerization. It has a binding affinity of 16 nM for the SARS-CoV-2 spike RBD, and effectively inhibits the SARS-CoV-2 pseudovirus in Huh7-hACE2 cells with an IC50 of 190 nM and neutralizes the authentic SARS-CoV-2 in Caco2 cells with an IC50 of 2.4 μM. Our study should provide a new insight for the optimization of peptide-based anti-SARS-CoV-2 inhibitors.

Graphical abstract: Neutralizing SARS-CoV-2 by dimeric side chain-to-side chain cross-linked ACE2 peptide mimetics

Supplementary files

Article information

Article type
Communication
Submitted
09 Nov 2021
Accepted
20 Dec 2021
First published
18 Jan 2022

Chem. Commun., 2022,58, 1804-1807

Neutralizing SARS-CoV-2 by dimeric side chain-to-side chain cross-linked ACE2 peptide mimetics

Y. Zhang, Y. Zhang, S. Su, H. Zhu, W. Xu, L. Wang, M. Wu, K. Chen, F. Yu, T. Xi, Q. Zhou, Y. Xie, X. Qin, H. Ge, L. Lu, J. Qing and G. Fang, Chem. Commun., 2022, 58, 1804 DOI: 10.1039/D1CC06301D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements